FNCB Bancorp, Inc. Announces Fourth Quarter and Year to Date 2023 Earnings

Stock Information for Adaptimmune Therapeutics plc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Adaptimmune Therapeutics plc

Peoples Financial Services Corp. and FNCB Bancorp, Inc. Announce Receipt of Regulatory Approvals for Merger
FNCB Bancorp, Inc. Announces First Quarter 2024 Earnings
FNCB Bancorp, Inc. Declares Second Quarter 2024 Dividend
Peoples Financial Services Corp. and FNCB Bancorp, Inc. Announce Receipt of Shareholder Approval for Merger
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates FNCB, PWFL, DOC, GRPH
FNCB BANCORP INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FNCB Bancorp, Inc. - FNCB
FNCB Bancorp, Inc. Declares First Quarter 2024 Dividend
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTA, FNCB, SLGC

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.